-Caveat Lector-

From
http://www.citizen.org/hrg/NEWSLETTERS/pillnews.htm

{{<Beginning of article>}}

Do Not Use!
Zanamivir (RELENZA) for the Flu--Cost Without Benefit
The Food and Drug Administration (FDA) approved Glaxo Wellcome's zanamivir
(RELENZA) for the treatment of type A and type B influenza in late July 1999.
Earlier in the year the FDA's Antiviral Drug Advisory Committee of 17 outside
experts reviewed zanamivir and voted 13 to 4 not to recommend it for approval
because of insufficient evidence that it is, in fact, effective for treating
flu. One committee member remarked during the meeting "... there isn't
sufficient efficacy to warrant [my] recommending this drug for my family or
myself."
Zanamivir will be on pharmacy shelves by the time you read this--just in time
for the flu season. It must be administered within the first 48 hours after the
onset of flu symptoms and is administered as a dry powder through an oral
inhalation device. The dose is two inhalations twice daily for five days. The
cost for the five-day course of treatment at a Washington DC chain pharmacy is
$52.99.
Little information is available about the effectiveness of zanamivir, other
than what Glaxo Wellcome has chosen to make available. Of course, this is
almost always the good news. Drug companies control nearly all the information
about a new drug, from results of the first injection into a laboratory animal
to the contacting and promotion to doctors and pharmacists--and now through
direct-to-consumer advertising of prescription drugs.

{{<End of excerpt>}}

A<>E<>R
~~~~~~~~~~~~~~~
Integrity has no need of rules. -Albert Camus (1913-1960)
+ + + + + + + + + + + + + + + + + + + + + + + + + + + +
The only real voyage of discovery consists not in seeking
new landscapes but in having new eyes. -Marcel Proust
+ + + + + + + + + + + + + + + + + + + + + + + + + + + +
"Believe nothing, no matter where you read it, or who said
it, no matter if I have said it, unless it agrees with your
own reason and your common sense." --Buddha
+ + + + + + + + + + + + + + + + + + + + + + + + + + + +
It is preoccupation with possessions, more than anything else, that
prevents us from living freely and nobly. -Bertrand Russell
+ + + + + + + + + + + + + + + + + + + + + + + + + + + +
"Everyone has the right...to seek, receive and impart
information and ideas through any media and regardless
of frontiers." Universal Declaration of Human Rights
+ + + + + + + + + + + + + + + + + + + + + + + + + + + +
"Always do sober what you said you'd do drunk. That will
teach you to keep your mouth shut." Ernest Hemingway
+ + + + + + + + + + + + + + + + + + + + + + + + + + + +
Forwarded as information only; no endorsement to be presumed
+ + + + + + + + + + + + + + + + + + + + + + + + + + + +
In accordance with Title 17 U.S.C. section 107, this material
is distributed without charge or profit to those who have
expressed a prior interest in receiving this type of information
for non-profit research and educational purposes only.

DECLARATION & DISCLAIMER
==========
CTRL is a discussion and informational exchange list. Proselyzting propagandic
screeds are not allowed. Substance—not soapboxing!  These are sordid matters
and 'conspiracy theory', with its many half-truths, misdirections and outright
frauds is used politically  by different groups with major and minor effects
spread throughout the spectrum of time and thought. That being said, CTRL
gives no endorsement to the validity of posts, and always suggests to readers;
be wary of what you read. CTRL gives no credeence to Holocaust denial and
nazi's need not apply.

Let us please be civil and as always, Caveat Lector.
========================================================================
Archives Available at:
http://home.ease.lsoft.com/archives/CTRL.html

http:[EMAIL PROTECTED]/
========================================================================
To subscribe to Conspiracy Theory Research List[CTRL] send email:
SUBSCRIBE CTRL [to:] [EMAIL PROTECTED]

To UNsubscribe to Conspiracy Theory Research List[CTRL] send email:
SIGNOFF CTRL [to:] [EMAIL PROTECTED]

Om

Reply via email to